Doable predictive biomarkers for tumor response to mTOR inhibitors, as happen to be described in glioblastoma, breast and prostate cancer cells, would be the differential expression of mTOR pathway proteins, PTEN, AKT, and S6.[one] Thus, this data is predicated on preclinical assays, based on in vitro cultured tumor mobile lines, https://chir-09076161.blog5star.com/28898275/the-smart-trick-of-e7449-that-no-one-is-discussing